Skip to content
DigeZyme®
  • DigeZyme®
    • Introduction
    • Digestive Enzymes
    • Significance of Enzymes
    • Salient Features
  • Insights
    • Rationale
    • Importance of Origin
    • Advantages
    • Enzyme Activity
  • Benefits
    • Clinical
    • Safety
    • Stability
  • IP Rights
    • Patents
  • About Sabinsa
    • Newsroom
      • Press Releases
      • Articles
      • Media Coverage
      • Ads
      • FAQs
  • Contact Us

Press Release

Sabinsa Notifies Alchem as to Status of Its Forskolin(ForsLean®) Patent

April 12, 2021May 5, 2008 by Pavithra YN

Sabinsa Corporation announced today that it has notified Alchem International as to the status of its patent covering the use of Forskohlin (ForsLean®), and…

Categories Press Release

Sabinsa Secures Patent For ForsLean® in Canada

April 12, 2021February 25, 2008 by Pavithra YN

Sabinsa Corporation today announced that it has secured a patent in Canada for its branded ingredient ForsLean® , a standardized extract of Coleus forskohlii…

Categories Press Release

Sabinsa Sues to Protect Its Piperine (BioPerine®) and Forskolin (ForsLean®) Patents

April 12, 2021July 25, 2007 by Pavithra YN

Sabinsa Corporation announced today that it has sued BioGreen NutraChem Inc. in the United States District Court in the Eastern District of New York for infring…

Categories Press Release

Sabinsa Successfully Protects Its Piperine (BioPerine®) and Forskolin (ForsLean®) Patents

April 12, 2021July 2, 2007 by Pavithra YN

Sabinsa Corporation announced today that it has successfully concluded its patent infringement lawsuit against DNP International, Inc. in the United States Dist…

Categories Press Release

Sabinsa Corporation is Awarded Thomas Alva Edison Patent Award

April 12, 2021November 23, 2004 by Pavithra YN

Sabinsa Corporation, a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals, was awarded…

Categories Press Release

ForsLean® Improves Body Composition According to Study Published In The Journal of Obesity Research

April 12, 2021October 3, 2004 by Pavithra YN

A recent study published in the August 2005 Journal of Obesity Research entitled “Body Composition and Hormonal Adaptations…

Categories Press Release

Sabinsa Successfully Defends Patent Infringement Lawsuit Against GCI Nutrients

April 12, 2021April 22, 2003 by Pavithra YN

Sabinsa Corporation has once again successfully protected its intellectual property (IP). Mark C. Sysler, Sabinsa’s Sr. EVP for Marketing and Sales today anno…

Categories Press Release

Sabinsa Wins ForsLean® Patent Infringement Suit Against Indfrag Ltd.

April 12, 2021October 11, 2002 by Pavithra YN

Sabinsa Corporation Senior Executive Vice President, Mark C. Sysler announced today that a Final Judgment has been entered in the patent infringement lawsuit th…

Categories Press Release

Sabinsa ForsLean® Now Water Soluble

April 12, 2021May 29, 2002 by Pavithra YN

Sabinsa Corporation Senior Executive Vice President, Mark C. Sysler announced today that a Final Judgment has been entered in the patent infringement lawsuit…

Categories Press Release

Science Behind ForsLean® Garners Best New Dietary Supplement Product of The Year Award for Sabinsa

April 12, 2021July 17, 2001 by Pavithra YN

Sami Labs, Ltd., the research and manufacturing arm of Sabinsa Corporation, was recently notified that it will be the recipient of two Export awards for the year…

Categories Press Release
Older posts
Newer posts
← Previous Page1 Page2 Page3 Next →

Search

About Sabinsa

Sabinsa is a manufacturer, supplier and marketer of herbal extracts, cosmeceuticals, minerals, dietary supplements and specialty fine chemicals for the nutritional, cosmetic, pharmaceutical and food industries.

Read More..

Certificates

Kosher IFANCA Halal Certified
Non-GMO

Headquarters

Sabinsa Corporation

20 Lake Drive 

East Windsor

NJ 08520, USA

 

Tel : +1 732 777 1111

Fax: +1 732 777 1443

info@sabinsa.com

Global Contact List

USA India
Utah, USA Japan
Australia Poland
Brasil Korea
Canada South Africa
China Vietnam
Germany  

Contact us

    © 2025 Sabinsa. All Rights Reserved | Powered by Edkal Technologies | Privacy Policy | Sitemap | Terms of Use | Disclaimer

    ×

    Disclaimer

    US-FDA: This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Usage disclaimer: The information pertaining to any marketing materials by Sabinsa, is for general purposes only. Users are urged to check the validity of patents if any, on any Sabinsa items for their intended use.

    EFSA: This statement has not been evaluated by the EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Australia: Please note as an ingredient supplier the information contained in this website is for marketers of finished products formulations and is not intended as consumer advice. Marketers should ensure finished products are lawful and comply with the regulations of the countries in which these items are sold. Every care has been taken to ensure the accuracy of the information provided at the time of publication.